Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Venkata Lokesh Battula
immunotherapy and AML
Paul Beavis
immunotherapy in myeloma
Eric Padron
CMML
Fenghuang Zhan
Myeloma and bone disease
Siegfried Janz
Myeloma immunotherapy
Rajni Kumari
AML
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Michael Kharas
leukemia
Jeremy Baeten
AML
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Christian Marinaccio
MLL leukemias
Soheil Meshinchi
pediatric AML
Christine Zhang
AML
Gianpietro Dotti
CAR T and AML
Qing Yi
Novel CAR-T
Stephen Nimer
myeloid cancer biology
Shannon Maude
Immunotherapy for ALL
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Andrew Lane
BPDCN
Xu Ji
Equity in Access
Hong Wen
AML
William Matsui
Myeloma
Huda Salman
CMML
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM
Pooja Khandelwal
bone marrow transplantation
Steven Treon
Lymphomas and Waldenstrom's
Carma Bylund
Equity in Access
Roberta Zappasodi
lymphoma, immunotherapy
Coleman Lindsley
AML/MDS
Nirav Shah
CAR-T for lymphoma
Paolo Caimi
CAR-T clinical trial for CLL
Catherine Smith
leukemia
Jennifer Amengual
lymphomas after transplant
Mark Hamilton
DLBCL and CAR-T
Nicolas Nassar
pediatric leukemia
F. Lennie Wong
Equity in Access
Siddhartha Jaiswal
preleukemia
Nizar Bahlis
Myeloma immunotherapy
Courtney Jones
AML metabolism
Matthew Frank
Lymphoma CART therapy
Solu Therapeutics
immunotherapy, CMML
Ronald Levy
immunotherapies, COVID-19
Meng Li
Equity in Access
Noemí Puig Morón
Myeloma
Shazia Nakhoda
Equity in Access
Omar Abdel-Wahab
Hairy cell leukemia
Jing Fu
myeloma
Ari Melnick
epigenetics and lymphoma
Mala Shanmugam
myeloma
Andrew Hantel
Equity in Access
Craig Jordan
AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Eugenio Morelli
Myeloma
Stacie Dusetzina
Equity in Access
Joachim Yahalom
Lymphoma
Lindsey Montefiori
pediatric leukemia
Sheng Li
Aging and AML
Brian Dalton
DNA mutations and myeloid cancers
Christian Steidl
B-cell lymphomas
Nataly Cruz-Rodriguez
T-ALL and metabolism
Richard Lock
T-ALL
Robert Orlowski
(Smoldering) Multiple Myeloma
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Julia Paczkowska
immunobiology of Hodgkin's disease
Yan Liu
MDS
Carl Allen
pediatric blood cancers
Thomas LeBlanc
palliative care
Cailin Collins
Leukemia and pre-leukemia
Jianguo Tao
Mantle Cell Lymphoma
Daniel Thomas
Myelofibrosis
John Crispino
myelofibrosis, pediatric leukemia and Downs
Nicoletta Cieri
AML and transplantation
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Steven Park
follicular lymphoma
Taishi Yonezawa
AML
Michael Savona
MDS and leukemia
Logan Spector
childhood leukemia epidimiology
Neha Mehta-Shah
T-cell lymphoma
Jing Yang
Myeloma
Jake Shortt
precision therapy for aggressive lymphomas
Catriona Jamieson
cancer stem cell biology
Anouchka Laurent
T-cell lymphoma
Fahmin Basher
transplant and GvHD
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Jaehyuk Choi
T-cell lymphoma
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Piers Patten
COVID-19
Elliot Stieglitz
CMML
Enterome
vaccine, FL, MZL
Ravindra Majeti
preleukemia, AML
Alieen Rowan
Adult T cell leukemia/lymphoma
Jennifer Trowbridge
aging and leukemia
Sarah Tasian
pediatric leukemias
Daisuke Nakada
preleukemia, leukemia
Nicola Vannini
Aging and CAR-T success
Michael Keller
COVID-19, immunotherapy
Alexey Danilov
lymphoma
Liran Shlush
pre-leukemia
Jessica Stewart
Epstein-barr virus and lymphomas
Tycel Phillips
Mantle Cell Lymphoma
Urvi Shah
Diet and myeloma
Raymond Mailhot
Equity in Access
Amit Verma
AML/MDS
Roland Walter
Antibody-based AML therapies
Hao Jiang
DNA biology and leukemia
Brian Walker
smoldering myeloma, MGUS
Adam de Smith
pediatric ALL and Down Syndrome
Affimed
immunotherapy, HL, PTCL
Lucy Godley
preleukemia
Yiman Liu
Epigenetics and leukemia
Eric Pietras
AML
Stephen Gottschalk
pediatric leukemia and CAR-T
Ravi Bhatia
transplantation
Peter Klein
MDS
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Kerry Rogers
CLL
Mark Murakami
follicular lymphoma
Jennifer Woyach
CLL trials
Catherine Diefenbach
DLBCL immunology
Adam Olszewski
Follicular and marginal zone lymphoma
Robert Soiffer
transplantation
Paolo Strati
Non-Hodgkin Lymphoma
Daphne Friedman
Equity in Access
Suzanne Lentzsch
Myeloma
Sahand Hormoz
MPN
Mark Dawson
B-ALL and CAR-T resistance
Jalpa Doshi
Equity in Access
Courtney DiNardo
clinical trials, AML
Michael Wang
Mantle Cell Lymphoma
Jeetayu Biswas
splicing in myeloid diseases
Kathleen Sakamoto
pediatric AML
Rachel Mersfelder
AMKL
Julia Maxson
AML
Wendy Béguelin
follicular lymphoma
Daniel Pollyea
AML
Christopher Flowers
clinical trial access
Lev Kats
myeloma and epigenetics
Keisuke Ito
blood cancer stem cells and MDS metabolism
Philippe Armand
follicular lymphoma
Jun Qi
Myeloma
Bingyi Chen
AML immunotherapy
Tyler Parsons
MPN and AML
Christopher Booth
BPDCN
Suman Paul
T cell cancers and immunotherapy
ImCheck Therapeutics
immunotherapy, AML
Christopher Porter
Leukemia, lymphoma
Michaela Reagan
Multiple Myeloma
Timothy Graubert
AML and MDS biology
Adi Nagler
Bronchiolitis obliterans after transplant
Justine Kahn
pediatric leukemia and lymphoma
Catherine Bollard
pediatric blood cancers and immunotherapy
George Vassiliou
Leukemia Prevention
Enrico Tiacci
Hairy cell leukemia
James Rubenstein
Lymphoma of the Central Nervous System
Marina Konopleva
MDS/AML metabolism
Grant Challen
preleukemia, leukemia
Tanya Siddiqi
clinical trial access
Martin Dreyling
Mantle Cell Lymphoma
George Daley
"off-the-shelf" CAR-T and CAR-NK
Sriram Sundaravel
AML stem cells
Lawrence Boise
CART and myeloma
Srividya Swaminathan
pediatric, immunotherapy
Jolanta Grembecka
leukemia therapeutics
Constellation Pharmaceuticals
myeloproliferative neoplasms
Ricky Johnstone
lymphoma and myeloma
Mendel Goldfinger
MDS/AML trials for the elderly
Sigurður Kristinsson
Smoldering myeloma
Jonas Jutzi
myeloproliferative neoplasms
Grzegorz Nowakowski
Clinical trial access
Simona Colla
Myeloma biology
Marc Seifert
Hairy cell leukemia
Anthony Letai
improving CAR-T
BioInvent International
immunotherapy, indolent NHL, CTCL
Takeshi Sugio
T-cell lymphoma
Jonathan Licht
DNA biology, myeloma
Caner Saygin
T-ALL
Frederick Locke
lymphoma and immunotherapy
Britta Will
Leukemia and pre-leukemia
Carl June
CAR T immunotherapy
Jayna Mistry
aging and leukemias
Yubin Zhou
peripheral T cell lymphoma
Ann-Kathrin Eisfeld
Racial diversity in AML
Sam Butterworth
CMML
Steven Horwitz
T-cell lymphomas
Caroline Arber
myeloma CAR-T
Michael Green
lymphoma biology
John DiPersio
trispecific antibody for AML and MDS
Anushree Vichare
Equity in Access
John Leonard
lymphoma research
Megan McNerney
AML/MDS
Tomasz Skorski
myeloproliferative neoplasms, AML
Madhav Dhodapkar
multiple myeloma immunotherapy
Maximilian Stahl
AML immunotherapy
Inhye Ahn
CLL
Dane Vassiliadis
blood cancer biology
Jianhua Yu
myeloma immunotherapy
Leandro Cerchietti
DLBCL
Auron Therapeutics
degrader, AML, MDS
Rgenta Therapeutics
RNA-targeting, blood cancer
Armin Rashidi
gut bacteria and transplant success
Peter Croucher
Multiple Myeloma
Trent Hall
MDS
Rong Lu
preleukemia, leukemia
Sergei Doulatov
Leukemias
Bruno Paiva
smoldering myeloma
Reina Takeda
AML
Ruben Carrasco
Myeloma
Dan Landau
cancer evolution biology
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Eirini Papapetrou
blood cancer stem cells
Kasey Leger
pediatric blood cancers
Matteo Bellone
Smoldering multiple myeloma
Daniel Lucas
bone marrow and leukemia biology
Tak Mak
Immunotherapy
Rizwan Romee
Immunotherapy
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Nitin Jain
CLL
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Margaret Shipp
lymphoma biology
Randall Davis
CLL
Helen Parsons
Equity in Access
Jenny Wang
AML
Daniel Herranz
T-ALL
Ana Vujovic
AML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Yibin Yang
Lymphoma
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
H. Irene Su
Equity in Access
Caron Jacobson
lymphoma and immunotherapy
Jonathon Cohen
lymphoma clinical trial access in Georgia
Kura Oncology
MLL leukemia, AML
Oreofe Odejide
Equity in Access
Pietro Genovese
transplant and AML
Wendy Stock
T-cell ALL
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Qingyu Luo
BPDCN
Lori Muffly
Equity in Access
Sham Mailankody
Myeloma immunotherapy clinical trials
Kimberly Stegmaier
childhood blood cancers
Bing Carter
p53 mutant AML
Manyi Wei
acute megakaryoblastic leukemia
Alfred Garfall
myeloma immunotherapy
Marco Ruella
Immunotherapy for T-cell lymphoma
Yoke Seng Lee
AML
Liling Wan
AML
Koichi Takahashi
AML/MDS
Markus Muschen
leukemia and lymphoma biology
Bailee Kain
AML and African ancestry
Faron Pharmaceuticals
immunotherapy, MDS
Thomas Kipps
Hairy Cell Leukemia
Kirk Schultz
pediatric transplantation
Thomas Koehnke
leukemia
Jean Koff
Disparities in DLBCL
Saar Gill
AML immunotherapy
Teresa Palomero
Peripheral T-cell Lymphoma
Alex Kentsis
pediatric leukemias
Jeffrey Magee
pediatric AML
Dimericon Therapeutics
dimericons, blood cancer
Luca Busino
DLBCL
Gaurav Goyal
Erdheim-Chester Disease